Dermatology (Basel, Switzerland)
(ISSN: 1018-8665, 1421-9832)
Dermatology (Basel, Switzerland)'s Latest Table of Contents
2016 - 232 (3)
- How Much Do We Know about Maintaining Treatment Response after Successful Acne Therapy? Systematic Review on the Efficacy and Safety of Acne Maintenance Therapy.
- Dermoscopic and Immunohistochemical Changes in Acquired Melanocytic Nevi following Narrow-Band Ultraviolet B Therapy.
- What Is New in Melanoma Genetics and Treatment?
- Hidradenitis Suppurativa: Terminology.
- Complete Penetrance and Absence of Intrafamilial Variability in a Large Family with Hereditary Leiomyomatosis and Renal Cell Carcinoma.
- Increased Levels of Total p-Cresylsulfate Are Associated with Pruritus in Patients with Chronic Kidney Disease.
- Reply to Revuz' Letter Entitled 'Hidradenitis Suppurativa: Terminology'.
- Dynamic Optical Coherence Tomography in Dermatology.
- Patient Adherence to Biologic Agents in Psoriasis.
- Treatment Satisfaction in Psoriasis: Development and Use of the PsoSat Patient Questionnaire in a Cross-Sectional Study.
- ING4 Inhibits Proliferation and Induces Apoptosis in Human Melanoma A375 Cells via the Fas/Caspase-8 Apoptosis Pathway.
- Nevoid Basal Cell Carcinoma Syndrome: Report from the Zurich Nevoid Basal Cell Carcinoma Syndrome Cohort.
- Author's Reply to the Response to the Commentary of Naldi and Cazzaniga Entitled 'Are All Screening Programmes Created Equal? The Case of Melanoma'.
- Oral Psoriasis: An Overlooked Enigma.
- Response to the Commentary of Naldi and Cazzaniga Entitled 'Are All Screening Programmes Created Equal? The Case of Melanoma'.
- Investigation of Enthesopathy with Ultrasonography and Comparison with Skin Findings in Asymptomatic Psoriatic Patients.
- Squamocellular Carcinoma of the Skin: Clinicopathological Features Predicting the Involvement of the Surgical Margins and Review of the Literature.
- Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies.
- Effectiveness of Barrier Creams against Irritant Contact Dermatitis.